Get started
Author

Javier Marco‐Hernández

Observed names: J Marco Hernandez, J Marco-Hernández, J. Marco- Hernández, J. Marco-Hernández, Javier Marco-Hernandez, Javier Marco-Hernández, Marco-Hernandez, Javier, Marco-Hernández, Javier, Marco-Hernández1, Javier
Observed institutions: Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Hospital Italiano de Buenos Aires, Sociedad Española de Medicina Interna, Hospital Clínic de Barcelona, Azienda Ospedaliero Universitaria Maggiore della Carita, Barcelona Institute for Global Health, Piedmont Reference Center for Epidemiology and Cancer Prevention, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona
ORCID: 0000-0001-8486-5404
Observed ORCID: 0000-0001-8486-5404
OpenAlex ID: A5022223456
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
2020 · David J. Pinato, Alberto Zambelli, et al. · Cancer Discovery · 184
PDF
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
2021 · David J Pinato, Josep Tabernero, et al. · The Lancet Oncology · 134
PDF
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
2022 · David J Pinato, Daniela Ferrante, et al. · The Lancet Oncology · 81
PDF
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry
2021 · OnCovid Study Group, David J. Pinato, et al. · JAMA Oncology · 72
PDF
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis
2022 · Marc Corbera-Bellalta, Roser Alba-Rovira, et al. · Annals of the Rheumatic Diseases · 63
PDF
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe
2020 · David J. Pinato, Alvin J. X. Lee, et al. · Cancers · 61
PDF
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
2021 · David J. Pinato, Lorenza Scotti, et al. · European Journal of Cancer · 49
PDF
Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients
2017 · Sergio Prieto-González, Nekane Terrades-García, et al. · RMD Open · 48
PDF
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19
2021 · Carolina Garcia-Vidal, Rodrigo Alonso, et al. · Journal of Antimicrobial Chemotherapy · 47
PDF
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
2021 · Gino M Dettorre, Saoirse Dolly, et al. · Journal for ImmunoTherapy of Cancer · 41
PDF
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
2023 · Alessio Cortellini, Josep Tabernero, et al. · The Lancet Oncology · 35
PDF
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
2022 · David J. Pinato, Daniela Ferrante, et al. · European Journal of Cancer · 31
PDF
Characterisation and Outcomes of Patients with Solid Organ Malignancies Admitted to the Intensive Care Unit: Mortality and Impact on Functional Status and Oncological Treatment
2024 · Marta García de Herreros, Juan Carlos Laguna, et al. · Diagnostics · 25
PDF
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients
2022 · Verónica Rico-Caballero, Mariana Fernández, et al. · Infection · 22
PDF
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
2022 · Alessio Cortellini, Alessandra Gennari, et al. · JNCI Journal of the National Cancer Institute · 20
PDF
Prevalence of ethical dilemmas in advanced cancer patients (secondary analysis of the PALCOM study)
2020 · Albert Tuca, Margarita Viladot, et al. · Supportive Care in Cancer · 20
Validation Study of the PALCOM Scale of Complexity of Palliative Care Needs: A Cohort Study in Advanced Cancer Patients
2023 · Margarita Viladot, Jose-Luís Gallardo-Martínez, et al. · Cancers · 14
PDF
The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia
2021 · Gerard Espinosa, Sergio Prieto-González, et al. · Clinical Rheumatology · 14
PDF
Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation
2018 · Òscar Miró, Patricia Javaloyes, et al. · The American Journal of Cardiology · 14
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
2022 · Ana M. Camon, Rodrigo Alonso, et al. · Scientific Reports · 13
PDF
The BRONCH-AHF study: Effects on short-term Outcome of Nebulized Bronchodilators in Emergency Department Patients Diagnosed with Acute Heart Failure
2017 · Òscar Miró, Josep Tost, et al. · European Journal of Heart Failure · 11
PDF
Severe Immune-Related Adverse Events: A Case Series of Patients Needing Hospital Admission in a Spanish Oncology Referral Center and Review of the Literature
2022 · Elia Seguí, Carles Zamora-Martínez, et al. · Diagnostics · 10
PDF
ANCA-associated vasculitic neuropathy during treatment with ipilimumab
2019 · Michelle Villarreal-Compagny, Pablo Iglesias, et al. · Rheumatology · 9
Interstitial pneumonitis and myelosuppression associated to mitomycin C urinary tract instillations: A case report
2018 · Montserrat Rodriguez-Reyes, Javier Marco-Hernandez, et al. · Journal of Oncology Pharmacy Practice · 9
Evolution of Complexity of Palliative Care Needs and Patient Profiles According to the PALCOM Scale (Part Two): Pooled Analysis of the Cohorts for the Development and Validation of the PALCOM Scale in Advanced Cancer Patients
2024 · Albert Tuca, Margarita Viladot, et al. · Cancers · 8
Works count: 71
Citation count: 1,220
H-index: 17
I10-index: 23
Year
Topic
Type